New England Journal Of Medicine Publishes Results Of Global, Multicenter Enrgy Study ...
Zenocutuzumab helps fill an important need for patients with advanced pancreatic cancer and NSCLC with NRG1 gene fusions, said Alison Schram M.D., ...
New England Journal Of Medicine Publishes: Efficacy Of Zenocutuzumab In NRG1 Fusion ...
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinic ...